These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 506621)

  • 1. Emergency treatment of portal-systemic encephalopathy with lactulose enemas. A controlled study.
    Van Waes L; van Egmond J; Demeulenaere L
    Acta Clin Belg; 1979; 34(3):122-9. PubMed ID: 506621
    [No Abstract]   [Full Text] [Related]  

  • 2. The rectal administration of lactulose.
    Ratnaike RN; Hicks EP; Hislop IG
    Aust N Z J Med; 1975 Apr; 5(2):137-40. PubMed ID: 240347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of patients with chronic liver diseases with lactulose and bifidum milk. Principles and problems].
    Müting D
    Fortschr Med; 1988 Jun; 106(17):369-72. PubMed ID: 3402892
    [No Abstract]   [Full Text] [Related]  

  • 4. Enterococcus lactic acid bacteria strain SF68 and lactulose in hepatic encephalopathy: a controlled study.
    Loguercio C; Del Vecchio Blanco C; Coltorti M
    J Int Med Res; 1987; 15(6):335-43. PubMed ID: 3125077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of basal arterial ammonemia and of orally-induced hyperammonemia in chronic portal systemic encephalopathy, treated with neomycin, lactulose, and an association of neomycin and lactulose.
    Pirotte J; Guffens JM; Devos J
    Digestion; 1974; 10(6):435-44. PubMed ID: 4448315
    [No Abstract]   [Full Text] [Related]  

  • 6. [Emergency treatment of hepatic coma and porto-caval encephalopathy].
    Imler M
    Bull Soc Sci Med Grand Duche Luxemb; 1973 Nov; 110(2):239-55. PubMed ID: 4589247
    [No Abstract]   [Full Text] [Related]  

  • 7. Lactulose: a crucial element in treating hepatic encephalopathy.
    Gever LN
    Nursing; 1982 Aug; 12(8):76-8. PubMed ID: 6920588
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical management of type C hepatic encephalopathy.
    Ridola L; Riggio O; Gioia S; Faccioli J; Nardelli S
    United European Gastroenterol J; 2020 Jun; 8(5):536-543. PubMed ID: 32213035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy of portal-systemic encephalopathy: the practical and the promising.
    Weber FL
    Gastroenterology; 1981 Jul; 81(1):174-7. PubMed ID: 7239116
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of chronic portal-systemic encephalopathy with lactulose. Report of six patients and review of the literature.
    Bircher J; Haemmerli UP; Scollo-Lavizzari G; Hoffmann K
    Am J Med; 1971 Aug; 51(2):148-59. PubMed ID: 5095524
    [No Abstract]   [Full Text] [Related]  

  • 11. [Lactulose and portocaval encephalopathy: value of its administration by rectal route].
    Chevrel B
    Med Chir Dig; 1977; 6(5):309-12. PubMed ID: 916764
    [No Abstract]   [Full Text] [Related]  

  • 12. Lactulose in the treatment of chronic portal-systemic encephalopathy. A double-blind clinical trial.
    Elkington SG; Floch MH; Conn HO
    N Engl J Med; 1969 Aug; 281(8):408-12. PubMed ID: 4894464
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hyperammoniemia and porta-caval encephalopathy in patients with cirrhosis. Personal results of lactulose treatment].
    Butti A; Bianco S; Bergonzi P; Cagossi M; Civello IM; Borzone A; Nanni G; Pigliucci GM
    Chir Patol Sper; 1975 Apr; 23(2):77-95. PubMed ID: 1140038
    [No Abstract]   [Full Text] [Related]  

  • 14. Orthograde whole gut irrigation with mannite versus paromomycine + lactulose as prophylaxis of hepatic encephalopathy in patients with cirrhosis and upper gastrointestinal bleeding: results of a controlled randomized trial.
    Tromm A; Griga T; Greving I; Hilden H; Hüppe D; Schwegler U; Micklefield GH; May B
    Hepatogastroenterology; 2000; 47(32):473-7. PubMed ID: 10791216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lactulose enemas in the treatment of hepatic encephalopathy. Do we help or harm?
    de Lorenzo-Pinto A; García-Sánchez R; Lorenzo-Salinas A
    Rev Esp Enferm Dig; 2017 Oct; 109(10):736-737. PubMed ID: 28929776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Branched-chain amino acids vs lactulose in the treatment of hepatic coma: a controlled study.
    Rossi-Fanelli F; Riggio O; Cangiano C; Cascino A; De Conciliis D; Merli M; Stortoni M; Giunchi G
    Dig Dis Sci; 1982 Oct; 27(10):929-35. PubMed ID: 6749458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic Encephalopathy.
    Blei AT; Córdoba J;
    Am J Gastroenterol; 2001 Jul; 96(7):1968-76. PubMed ID: 11467622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of coma in liver cirrhosis].
    Manenti F; Ferrari A
    Clin Ter; 1975 Jul; 74(1):3-12. PubMed ID: 1222514
    [No Abstract]   [Full Text] [Related]  

  • 19. [Changes in the levels of ammonia and free phenols in patients with portocaval shunt treated with lactulose and/or neomycin compared to a low protein diet (author's transl)].
    Leonhardt H; Sanhueza P
    Med Klin; 1978 Jan; 73(2):63-8. PubMed ID: 622058
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatic encephalopathy: pathophysiology and advances in therapy.
    Av SP
    Trop Gastroenterol; 2007; 28(1):4-10. PubMed ID: 17896602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.